COMT and Parkinson disease: Existing randomized trials of COMT inhibitors in early PD without motor fluctuations have yielded equivocal results potentially related to study designs, and the results of the ongoing ADOPTION and EPSILON studies will provide more insights on the benefits of earlier time points to initiate therapy with COMT inhibitors (see Sect.